HDAC/HSP90-IN-3 structure
|
Common Name | HDAC/HSP90-IN-3 | ||
---|---|---|---|---|
CAS Number | 2700035-54-5 | Molecular Weight | 511.57 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H33N5O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HDAC/HSP90-IN-3HDAC/HSP90-IN-3 (compound J5) is a potent and selective fungal Hsp90 and HDAC dual inhibitor, with IC50 values of 0.83 and 0.91 μM, respectively. HDAC/HSP90-IN-3 shows antifungal activity against azole resistant C. albicans. HDAC/HSP90-IN-3 can suppress important virulence factors and down-regulate drug-resistant genes ERG11 and CDR1[1]. |
Name | HDAC/HSP90-IN-3 |
---|
Description | HDAC/HSP90-IN-3 (compound J5) is a potent and selective fungal Hsp90 and HDAC dual inhibitor, with IC50 values of 0.83 and 0.91 μM, respectively. HDAC/HSP90-IN-3 shows antifungal activity against azole resistant C. albicans. HDAC/HSP90-IN-3 can suppress important virulence factors and down-regulate drug-resistant genes ERG11 and CDR1[1]. |
---|---|
Related Catalog | |
Target |
HSP90:0.83 μM (IC50, fungal Hsp90) HDAC:0.91 μM (IC50, fungal HDACs) human HDAC:3.0 μM (IC50, human HDACs) HSP90:19.52 μM (IC50, human Hsp90) |
In Vitro | HDAC/HSP90-IN-3 (compound J5) significantly down-regulates the adherence-related genes (such as ALS3, HWP1, EAP1, BCR1), and down-regulates the expression of ERG11 and CDR1[1]. |
References |
Molecular Formula | C26H33N5O6 |
---|---|
Molecular Weight | 511.57 |